Novavax Inc (NVAX)

$8.37 -0.32 (-3.68%)
Market Cap 1.44B
Revenue (ttm) 682.16M
Net Income (ttm) -187.50M
EPS (ttm) N/A
PE Ratio 3.90
Forward PE N/A
Profit Margin -27.49%
Debt to Equity Ratio 0.00
Volume 3,771,200
Avg Vol 4,494,408
Day's Range N/A - N/A
Shares Out 162.50M
Stochastic %K 13%
Beta 2.37
Analysts Sell
Price Target $12.89

Company Profile

Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax...

Industry: Biotechnology
Sector: Healthcare
Phone: 240 268 2000
Address:
700 Quince Orchard Road, Gaithersburg, United States
andy4343
andy4343 Feb. 4 at 12:24 PM
$NVAX Why would a Big Pharma company like Merck want to partner with Novavax in 2026? https://x.com/the43rdcaptain/status/2019023850332184598?s=46
0 · Reply
Peter4Parker
Peter4Parker Feb. 4 at 12:11 PM
$NVAX JJ is doing a good job and also does not ever overpromise. Yet now he says there is demand for MatrixM like never before and probably more deals on the way. That is a strong statement considering him saying it. This permanent noise about fucking proxy fight and incopetent BOD is just shorts' theme. There is more than 50 mil shares shorted and no fundamental reason for price going down in next few years. On the contrary. They will do whatever possible to not let the price go up. Only most stupid longs jumps on this train of nonsense. Dont be stupid and dont repeat their shit. Proxyfuckingthink!
1 · Reply
ddirk
ddirk Feb. 4 at 12:07 PM
$NVAX let’s hope JSE indicator will help out the SP
0 · Reply
Eternalpatience1
Eternalpatience1 Feb. 4 at 11:47 AM
$NVAX We have to figure out a way to ignite the short squeeze, not the fuse under JJs seat
0 · Reply
Eternalpatience1
Eternalpatience1 Feb. 4 at 11:44 AM
$NVAX Didn't we badmouth stan Erck to death on this board? And I feel we are doing the same to JJ NOW. I FEEL the real problem lies elsewhere in terms of the power that controls this stick (the shorts). A CEO role is to not fight the shorts but build the company string. While I am pissed with the stock, the company has definitely come along a great way of I look back the path. Oh well I tried to be positive in the AM
0 · Reply
Ivan_the_Great
Ivan_the_Great Feb. 4 at 11:17 AM
$NVAX It’s February and not a peep from Shah (not even after Pfizer deal). It tells me he’s still not pleased. Earnings around the corner. Perhaps management has something cooked up for investors to prevent the bloodbath (proxy fight) from taking place? Doubt it from these knuckleheads…
0 · Reply
DrSammy
DrSammy Feb. 4 at 10:55 AM
$NVAX Novavax is a public Company not Jacobs/Chairwoman Maggie’s superLotto office to issue lottery tickets to executive team and themselves! Shah Capital requests are all reasonable— Referencing Oct/Nov letters to board of directors! BODs Basic functions are oversight & accountability not to issue lottery tickets to executive team and themselves! Do your job!
1 · Reply
Benroxx
Benroxx Feb. 4 at 9:19 AM
$NVAX Why?
0 · Reply
holysquish
holysquish Feb. 4 at 9:05 AM
$NVAX Shorts are in big trouble here
0 · Reply
DrFUShorts
DrFUShorts Feb. 4 at 9:01 AM
$NVAX SC´s wrath will be unstoppable! Singlehandedly climbed the stairs to become one of the top major stakeholders. Accountability and oversight shall be restored. The wicked and corrupt will be swept from the face of the earth. So shall be it. Honor will come!
0 · Reply
Latest News on NVAX
Moderna Vs. Novavax: 2 Pandemic Vaccine Pioneers - Which Offers Better Value Today?

Jan 30, 2026, 10:09 AM EST - 4 days ago

Moderna Vs. Novavax: 2 Pandemic Vaccine Pioneers - Which Offers Better Value Today?

MRNA

Novavax Announces Entering into a License Agreement with Pfizer

Jan 20, 2026, 7:15 AM EST - 15 days ago

Novavax Announces Entering into a License Agreement with Pfizer

Novavax enters license agreement with Pfizer for vaccine development

Jan 20, 2026, 7:11 AM EST - 15 days ago

Novavax enters license agreement with Pfizer for vaccine development

PFE

Novavax, Inc. (NVAX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 14, 2026, 10:15 PM EST - 20 days ago

Novavax, Inc. (NVAX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Jan 7, 2026, 8:00 AM EST - 27 days ago

Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

Dec 1, 2025, 3:50 PM EST - 2 months ago

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

BNTX MRNA PFE

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

Dec 1, 2025, 12:35 PM EST - 2 months ago

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

BNTX MRNA PFE

Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals

Dec 1, 2025, 9:59 AM EST - 2 months ago

Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals

MRNA

Novavax, Inc. (NVAX) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 19, 2025, 2:33 PM EST - 2 months ago

Novavax, Inc. (NVAX) Presents at Jefferies London Healthcare Conference 2025 Transcript

Shah Capital pushes for Novavax sale, warns of proxy fight

Nov 12, 2025, 4:41 PM EST - 2 months ago

Shah Capital pushes for Novavax sale, warns of proxy fight

Novavax to Participate in Jefferies London Healthcare Conference

Nov 12, 2025, 8:00 AM EST - 2 months ago

Novavax to Participate in Jefferies London Healthcare Conference

Novavax, Inc. (NVAX) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 3:26 PM EST - 3 months ago

Novavax, Inc. (NVAX) Q3 2025 Earnings Call Transcript

Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights

Nov 6, 2025, 8:00 AM EST - 3 months ago

Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights

Novavax raises annual revenue forecast on strength of vaccine deals

Nov 6, 2025, 7:58 AM EST - 3 months ago

Novavax raises annual revenue forecast on strength of vaccine deals

Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment

Nov 4, 2025, 7:00 AM EST - 3 months ago

Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment

Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025

Oct 30, 2025, 8:00 AM EDT - 3 months ago

Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025

Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy

Oct 22, 2025, 7:00 AM EDT - 3 months ago

Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy

Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential

Oct 14, 2025, 1:08 PM EDT - 4 months ago

Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential

Shah Capital pushes for Novavax's sale on persistent underperformance, marketing missteps

Oct 14, 2025, 6:09 AM EDT - 4 months ago

Shah Capital pushes for Novavax's sale on persistent underperformance, marketing missteps

Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment

Oct 7, 2025, 7:00 AM EDT - 4 months ago

Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment

Novavax Announces Progress on Sanofi Agreement

Sep 30, 2025, 9:01 AM EDT - 4 months ago

Novavax Announces Progress on Sanofi Agreement

Mizuho's Jared Holz: There's not much value left in vaccine stocks

Sep 19, 2025, 11:40 AM EDT - 4 months ago

Mizuho's Jared Holz: There's not much value left in vaccine stocks

BNTX MRNA PFE

Novavax, Inc. (NVAX) Presents At Cantor Global Healthcare Conference 2025 Transcript

Sep 4, 2025, 2:10 PM EDT - 5 months ago

Novavax, Inc. (NVAX) Presents At Cantor Global Healthcare Conference 2025 Transcript

Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment

Sep 4, 2025, 8:00 AM EDT - 5 months ago

Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment

Novavax to Participate in the Cantor Global Healthcare Conference

Sep 3, 2025, 8:00 AM EDT - 5 months ago

Novavax to Participate in the Cantor Global Healthcare Conference

Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.

Aug 27, 2025, 3:07 PM EDT - 5 months ago

Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.

Novavax Announces Convertible Debt Refinancing

Aug 21, 2025, 7:43 AM EDT - 5 months ago

Novavax Announces Convertible Debt Refinancing

Novavax, Inc. (NVAX) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 3:56 PM EDT - 6 months ago

Novavax, Inc. (NVAX) Q2 2025 Earnings Call Transcript

Novavax beats quarterly revenue estimates on milestone payment

Aug 6, 2025, 8:08 AM EDT - 6 months ago

Novavax beats quarterly revenue estimates on milestone payment

Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights

Aug 6, 2025, 8:00 AM EDT - 6 months ago

Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights

Novavax to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 30, 2025, 8:00 AM EDT - 6 months ago

Novavax to Report Second Quarter 2025 Financial Results on August 6, 2025

Novavax Shares Promising Results For Bird Flu Vaccine, Tested In Primates

Jul 24, 2025, 11:02 AM EDT - 6 months ago

Novavax Shares Promising Results For Bird Flu Vaccine, Tested In Primates

Novavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical Study

Jul 24, 2025, 8:00 AM EDT - 6 months ago

Novavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical Study

Novavax, Inc. (NVAX) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript

Jun 11, 2025, 8:59 PM EDT - 8 months ago

Novavax, Inc. (NVAX) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript

Novavax's COVID-flu combo and standalone flu shots improve immunity in late-stage study

Jun 11, 2025, 7:11 AM EDT - 8 months ago

Novavax's COVID-flu combo and standalone flu shots improve immunity in late-stage study

Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial

Jun 11, 2025, 7:00 AM EDT - 8 months ago

Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial

Vaccine actions and policy positions under US Health Secretary Kennedy

Jun 10, 2025, 10:45 AM EDT - 8 months ago

Vaccine actions and policy positions under US Health Secretary Kennedy

BNTX MRNA PFE

Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up

Jun 10, 2025, 9:30 AM EDT - 8 months ago

Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up

BNTX MRNA PFE

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.

Jun 10, 2025, 8:18 AM EDT - 8 months ago

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.

BNTX MRNA PFE SNY

Novavax to Participate in Upcoming Investor Conferences

May 29, 2025, 8:00 AM EDT - 8 months ago

Novavax to Participate in Upcoming Investor Conferences

Novavax: Nuvaxovid FDA Approval Unlocks Several Bullish Stimuli

May 21, 2025, 8:15 AM EDT - 9 months ago

Novavax: Nuvaxovid FDA Approval Unlocks Several Bullish Stimuli

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

May 20, 2025, 4:34 PM EDT - 9 months ago

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

Top Stock Movers Now: Tesla, AutoZone, Novavax, and More

May 19, 2025, 12:15 PM EDT - 9 months ago

Top Stock Movers Now: Tesla, AutoZone, Novavax, and More

AZO TSLA

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker.

May 19, 2025, 9:27 AM EDT - 9 months ago

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker.

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

May 19, 2025, 7:16 AM EDT - 9 months ago

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine

May 19, 2025, 7:00 AM EDT - 9 months ago

U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine

FDA approves Novavax COVID vaccine with new conditions

May 17, 2025, 10:26 PM EDT - 9 months ago

FDA approves Novavax COVID vaccine with new conditions

Novavax, Inc. (NVAX) Presents at BofA Securities 2025 Health Care Conference (Transcript)

May 14, 2025, 10:46 PM EDT - 9 months ago

Novavax, Inc. (NVAX) Presents at BofA Securities 2025 Health Care Conference (Transcript)

Novavax: Initiating Hold Rating After Strong, But Misunderstood Q1 2025 Earnings Beat

May 12, 2025, 12:45 PM EDT - 9 months ago

Novavax: Initiating Hold Rating After Strong, But Misunderstood Q1 2025 Earnings Beat

COVID Vaccine Maker Novavax Stock Soars 16% - Here's Why

May 8, 2025, 1:31 PM EDT - 9 months ago

COVID Vaccine Maker Novavax Stock Soars 16% - Here's Why

andy4343
andy4343 Feb. 4 at 12:24 PM
$NVAX Why would a Big Pharma company like Merck want to partner with Novavax in 2026? https://x.com/the43rdcaptain/status/2019023850332184598?s=46
0 · Reply
Peter4Parker
Peter4Parker Feb. 4 at 12:11 PM
$NVAX JJ is doing a good job and also does not ever overpromise. Yet now he says there is demand for MatrixM like never before and probably more deals on the way. That is a strong statement considering him saying it. This permanent noise about fucking proxy fight and incopetent BOD is just shorts' theme. There is more than 50 mil shares shorted and no fundamental reason for price going down in next few years. On the contrary. They will do whatever possible to not let the price go up. Only most stupid longs jumps on this train of nonsense. Dont be stupid and dont repeat their shit. Proxyfuckingthink!
1 · Reply
ddirk
ddirk Feb. 4 at 12:07 PM
$NVAX let’s hope JSE indicator will help out the SP
0 · Reply
Eternalpatience1
Eternalpatience1 Feb. 4 at 11:47 AM
$NVAX We have to figure out a way to ignite the short squeeze, not the fuse under JJs seat
0 · Reply
Eternalpatience1
Eternalpatience1 Feb. 4 at 11:44 AM
$NVAX Didn't we badmouth stan Erck to death on this board? And I feel we are doing the same to JJ NOW. I FEEL the real problem lies elsewhere in terms of the power that controls this stick (the shorts). A CEO role is to not fight the shorts but build the company string. While I am pissed with the stock, the company has definitely come along a great way of I look back the path. Oh well I tried to be positive in the AM
0 · Reply
Ivan_the_Great
Ivan_the_Great Feb. 4 at 11:17 AM
$NVAX It’s February and not a peep from Shah (not even after Pfizer deal). It tells me he’s still not pleased. Earnings around the corner. Perhaps management has something cooked up for investors to prevent the bloodbath (proxy fight) from taking place? Doubt it from these knuckleheads…
0 · Reply
DrSammy
DrSammy Feb. 4 at 10:55 AM
$NVAX Novavax is a public Company not Jacobs/Chairwoman Maggie’s superLotto office to issue lottery tickets to executive team and themselves! Shah Capital requests are all reasonable— Referencing Oct/Nov letters to board of directors! BODs Basic functions are oversight & accountability not to issue lottery tickets to executive team and themselves! Do your job!
1 · Reply
Benroxx
Benroxx Feb. 4 at 9:19 AM
$NVAX Why?
0 · Reply
holysquish
holysquish Feb. 4 at 9:05 AM
$NVAX Shorts are in big trouble here
0 · Reply
DrFUShorts
DrFUShorts Feb. 4 at 9:01 AM
$NVAX SC´s wrath will be unstoppable! Singlehandedly climbed the stairs to become one of the top major stakeholders. Accountability and oversight shall be restored. The wicked and corrupt will be swept from the face of the earth. So shall be it. Honor will come!
0 · Reply
Ivan_the_Great
Ivan_the_Great Feb. 4 at 8:22 AM
$NVAX Big pharmas are running out of runway. They’ll have to innovate or start acquiring technologies to improve future cash flows. Cost reduction and enhanced technologies are a must in this environment. Investors demand it. https://www.cnbc.com/2026/02/04/novo-nordisk-stock-ceo-earnings-guidance-ozempic-wegovy.html
0 · Reply
Slim_M
Slim_M Feb. 4 at 7:13 AM
$NVAX Strategy to win over shorts is to run this up during overnight. They cant short then. Then they will haft to pour more shorts during market opens than it costs to run it up during overnight trading. That id the way. That is our ONLY edge against shorts.
1 · Reply
BigCheeze2014
BigCheeze2014 Feb. 4 at 5:36 AM
$NVAX When Jacobs is out, PPS will go to over $10 because lots of shorts will cover.
1 · Reply
BigCheeze2014
BigCheeze2014 Feb. 4 at 5:32 AM
$NVAX These small biotechs get the worst CEOs imaginable !
1 · Reply
BullTradingTips
BullTradingTips Feb. 4 at 3:35 AM
$NVAX https://jobs.sanofi.com/en/job/swiftwater/adjuvant-platform-head-vaccines/2649/30633209152 New job posting for Sanofi calls out Novavax without using their name… Sanofi has developed a number of diverse Adjuvant formulations internally and has access to others via external partnerships and collaborations. The Adjuvant technology is a critical component of successful vaccines based on recombinant protein technology and is likely to be a key success factor for such vaccines in the more scientifically challenging fields of the future, including therapeutic immunotherapies. Furthermore, we are evaluating the role of Adjuvants in potentiating responses to mRNA vaccines and polysaccharide conjugate technologies.
1 · Reply
DerFrank
DerFrank Feb. 4 at 3:10 AM
$NVAX This pig will see $6 again, soon... Pfizer deal not nearly as lucrative as Sanofi. Plus Sanofi has not expanded to other vaccines or tried to really market novavax shot. It's dead
0 · Reply
NioEVisBestEv
NioEVisBestEv Feb. 4 at 2:25 AM
$NVAX pamp
0 · Reply
DrSammy
DrSammy Feb. 4 at 1:20 AM
$NVAX Was busy w/ Family — is it true that Jacobs (3Yr) contract (/Massacre) is Over? Thanks! Be Gone Evil Short implant!
2 · Reply
wintogether
wintogether Feb. 4 at 12:11 AM
$NVAX well, at least they tried. A dog will remain a dog for the foreseeable future.
0 · Reply
taxplanr
taxplanr Feb. 3 at 10:50 PM
So the Epstein files show Bill Gates and Jeffrey Epstein planning the COVID pandemic in 2017 $MRNA $BNTX $PFE $NVAX https://www.instagram.com/reel/DUTrmJ4j5WU/?igsh=bGR3aXllZW0waDUx
2 · Reply
DoctorGlenn
DoctorGlenn Feb. 3 at 10:29 PM
$NVAX Just hold on they say! It’s only been 5 years! My arms are killing me!
0 · Reply
Slim_M
Slim_M Feb. 3 at 10:08 PM
$NVAX WHEN, not if... This one starts running. Many will become insolvent. 11.5 days to cover. Good Night!
4 · Reply